148 related articles for article (PubMed ID: 31680062)
1. Effects of oral contraceptive pretreatment on IVF outcomes in women following a GnRH agonist protocol.
Xu L; Ding L; Jiang J; Liu P; Wei D; Qin Y
Reprod Biomed Online; 2019 Dec; 39(6):924-930. PubMed ID: 31680062
[TBL] [Abstract][Full Text] [Related]
2. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
Xu Z; Meng L; Pan C; Chen X; Huang X; Yang H
Gynecol Endocrinol; 2019 Feb; 35(2):124-127. PubMed ID: 30303700
[TBL] [Abstract][Full Text] [Related]
3. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis.
Wu Y; Huang J; Zhong G; Lan J; Lin H; Zhang Q
Reprod Biomed Online; 2022 Feb; 44(2):380-388. PubMed ID: 34895827
[TBL] [Abstract][Full Text] [Related]
4. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
5. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
[TBL] [Abstract][Full Text] [Related]
6. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
[TBL] [Abstract][Full Text] [Related]
7. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
8. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
9. Comparison of luteal phase ovulation induction and ultra-short gonadotropin-releasing hormone agonist protocols in older patients undergoing in vitro fertilization.
Wang T; Sun Z; Lim JP; Yu Y
Libyan J Med; 2019 Dec; 14(1):1597327. PubMed ID: 30935302
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
11. MTHFR 677TT is associated with decreased number of embryos and cumulative live birth rate in patients undergoing GnRHa short protocol: a retrospective study.
Zeng H; Liu Z; Zhang L; Liu N
BMC Pregnancy Childbirth; 2022 Mar; 22(1):170. PubMed ID: 35232413
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.
Kolanska K; Cohen J; Bendifallah S; Selleret L; Antoine JM; Chabbert-Buffet N; Darai E; d'Argent EM
J Gynecol Obstet Hum Reprod; 2017 Nov; 46(9):681-686. PubMed ID: 28970135
[TBL] [Abstract][Full Text] [Related]
13. Is the long-acting gonadotropin-releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
Wang X; Li W; Chen X; Zhang W; Chu M; Yin S; Chu Y; Liu X
Int J Gynaecol Obstet; 2023 Jul; 162(1):325-332. PubMed ID: 36688363
[TBL] [Abstract][Full Text] [Related]
14. GnRHa flare and IVF pregnancy rates.
Confino E; Zhang X; Kazer RR
Int J Gynaecol Obstet; 2004 Apr; 85(1):36-9. PubMed ID: 15050465
[TBL] [Abstract][Full Text] [Related]
15. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
Daya S
Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
[TBL] [Abstract][Full Text] [Related]
17. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative.
Yu TN; Liu YL; Wang PH; Chen CH; Chen CH; Tzeng CR
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):656-661. PubMed ID: 31542088
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in
Umemmuo MU; Efetie ER; Agboghoroma CO; Momoh JA; Ikechebelu JI
Niger Postgrad Med J; 2020; 27(3):171-176. PubMed ID: 32687115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
